
Cigna (CI) Stock Forecast & Price Target
Cigna (CI) Analyst Ratings
Bulls say
Cigna Group is positioned well because its 3Q26 results showed resilient execution, with adjusted EPS of $7.98 beating consensus by $0.48 as CignaHealthcare pretax adjusted operating income reached $1.2B versus $1.1B expected and Evernorth was modestly ahead. Management reinforced confidence by raising CY26 adjusted EPS guidance to at least $30.60, lifting CignaHealthcare operating income guidance to above $4.6B, and setting a CY27 adjusted EPS floor of $33.00, supported by stop-loss recovery, stable medical cost trends, and strong selling season momentum. Its long-duration earnings thesis is further backed by high-90% PBM retention, the Centene win, a large DoD contract base, and the $3B Accelerate to One savings target by 2030, which should drive margin expansion and earnings durability.
Bears say
Cigna Group is facing a weakening fundamental outlook because its CignaHealthcare exit from the Individual ACA in 1/1/27 removes a business that generated $3.2B of CY26 premium revenue and about $113.3M of pretax adjusted operating income, creating an estimated ($0.60) CY27 adjusted EPS headwind. At the same time, Evernorth’s Pharmacy Benefit Services faces a CY27 rebating and GLP-1 headwind that could cut PBS pretax adjusted operating income by about $241.8M, while Specialty and Care Services is only expected to grow at the low end of its 8.0%-12.0% long-term target range. With management also warning of rebate-pool compression, stranded costs, and execution risk around pricing healthcare cost trend and biosimilar adoption, the company’s earnings base looks more fragile despite a large employer and government customer footprint.
This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.
Cigna (CI) Analyst Forecast & Price Prediction
Start investing in Cigna (CI)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Cigna (CI) Forecast
Cigna (CI) Analyst Forecast & Price Prediction
Start investing in Cigna (CI)
Order type
Buy in
Order amount
Est. shares
0 shares